Point72 Hong Kong’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,500
Closed -$738K 356
2022
Q3
$738K Buy
10,500
+4,200
+67% +$329K 0.03% 624
2022
Q2
$505K Sell
6,300
-1,400
-18% -$109K 0.02% 709
2022
Q1
$584K Sell
7,700
-33,100
-81% -$2.62M 0.02% 667
2021
Q4
$3.48M Sell
40,800
-58,400
-59% -$4.56M 0.12% 182
2021
Q3
$7.5M Buy
99,200
+43,900
+79% +$3.49M 0.24% 57
2021
Q2
$4.5M Buy
55,300
+23,900
+76% +$1.95M 0.15% 144
2021
Q1
$2.48M Buy
31,400
+23,000
+274% +$1.8M 0.08% 326
2020
Q4
$718K Buy
+8,400
New +$695K 0.03% 594

Other funds holding CL

Point72 Hong Kong's CL Position: Q2 2024 in Review

Point72 Hong Kong sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 209,251 shares — an estimated $18.8M sold.

Point72 Hong Kong first reported a position in CL in Q1 2017 and held it in 14 quarters. The position peaked at $18.8M in Q1 2024. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • Point72 Hong Kong reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 209,251 Colgate-Palmolive shares in Q2 2024, an estimated $18.8M.
  • Point72 Hong Kong first reported a position in Colgate-Palmolive in Q1 2017 and held it in 14 quarters.
  • Point72 Hong Kong's Colgate-Palmolive position peaked at $18.8M in Q1 2024.
  • 1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.